Validation of a New Scoring Scale for Behavioral Assessment of L-Dopa-Induced Dyskinesia in the Rat: A New Tool for Early Decision-Making in Drug Development-Reference-Cited by-同舟云学术

Validation of a New Scoring Scale for Behavioral Assessment of L-Dopa-Induced Dyskinesia in the Rat: A New Tool for Early Decision-Making in Drug Development

Published:2017-12-11 Issue:4 Volume:9 Page:762-772
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Loiodice Simon¹^ORCID,Denibaud Anne-Sophie¹,Deffains Wendy¹,Alix Magali¹,Montagne Pierre¹,Seffals Marine²,Drieu La Rochelle Christophe¹

Affiliation:

1. Non-Clinical Department, Biotrial Pharmacology, 7-9 rue Jean-Louis Bertrand, 35042 Rennes, France

2. Plate-Forme H2P2, Université de Rennes 1, Biosit, 2 Av. du Prof. Léon Bernard, 35043 Rennes, France

Funder

Biotrial

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.7b00426

Reference65 articles.

1. Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia

2. Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics

3. Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature

4. Risk factors for levodopa-induced dyskinesias in Parkinson's disease

5. Animal models of l-DOPA–induced dyskinesia: an update on the current options

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicolorimetric Sensor Array Based on Silver Metallization of Gold Nanorods for Discriminating Dopaminergic Agents;ACS Chemical Neuroscience;2024-08-19

2. Dyskinesia and Parkinson’s disease: animal model, drug targets, and agents in preclinical testing;Expert Opinion on Therapeutic Targets;2022-10-03

3. Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats;Neural Plasticity;2021-07-28

4. Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson’s disease;Behavioural Brain Research;2019-03

5. Viewpoint: Developing drugs for levodopa-induced dyskinesia in PD: Lessons learnt, what does the future hold?;European Journal of Neuroscience;2018-11-15